The binding of insulin to its receptor activates a phosphorylation cascade leading to the inhibition of GSK3β. When the activity of insulin signalling is disturbed, hyperphosphorylation of GSK3β occurs, which later causes an increase in TAU expression, a marker of AD [60]. Here, GSK3B is linked to Alzheimer disease.